Nanfang Hospital Southern Medical University
Nanfang Hospital Southern Medical University
Guangzhou, China5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| SAVE-PCI Ⅱ: NyokAssist™ Small-Bore VAD vs. ECMO in Elective High-Risk PCI | High-risk PCI | Recruiting | Not applicable | 2026-10-06 | NCT07860671 | |
| Rituximab, Pirtobrutinib, Lisaftoclax and Liposomal Mitoxantrone for for Richter Syndrome Transformed From CLL | Richter transformation | Not yet recruiting | Phase 2 | 2026-09-21 | NCT07831395 | |
| The Efficacy and Safety of Efsubaglutide Alfa Injection in Overweight and Obese Subjects (ENLIGHT) | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Active, not recruiting | Phase 2 / Phase 3 | 2026-01-30 | NCT06921486 | |
| SAVE-PCI: NyokAssist™ Small-Bore VAD vs. IABP in Elective High-Risk PCI | High-Risk PCI | Active, not recruiting | Not applicable | 2026-01-12 | NCT07010965 | |
| Adjuvant Treatment Based on MRD for EGFR Mutant NSCLC | MRD | Recruiting | Phase 2 | 2022-09-14 | NCT05536505 |